Ling Ma - NanoFCM Inc., Xiamen China

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 48 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

LA-D-B1, a Novel Abemaciclib Derivative, Exerts Anti-Breast Cancer Effects Through CDK4/6

Ma Ling, Zirui Jiang,Xiao Hou,Yuting Xu, Ziyun Chen,Siyi Zhang, Hanxue Li,Shaojie Ma, Geng Zhang,Xiujun Wang,Jing Ji

BIOCELL（2024）

引用0浏览0引用

First-line Camrelizumab (a PD-1 Inhibitor) Plus Apatinib (an VEGFR-2 Inhibitor) and Chemotherapy for Advanced Gastric Cancer (SPACE): a Phase 1 Study

SIGNAL TRANSDUCTION AND TARGETED THERAPYno. 1 (2024)

引用0浏览0WOSNATURE引用

Β-Catenin/tcf4-induced SCUBE3 Upregulation Promotes Ovarian Cancer Development Via HIF-1 Signaling Pathway

Jing Shen,Xinhui Ma, Zehui Wei,Qilan Qian,Aixin Jing,Yuanyuan Ding,Ting Geng,Jingting Qin,Ling Ma,Yulu Chen,Jing Ji,Bin Liu,Jinling Huang

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2024)

引用0浏览0WOS引用

Camrelizumab Combined with Gemcitabine and Apatinib in Treating Advanced PD-L1-positive Biliary Tract Cancers

Yitong Tian, Changxian Li, Ke Jin,Ling Ma, Jiaguang Zhang, Xinyi Zhang, Wei You, Haoyang Shen, Yuting Ding, Hao Qian,Xiangcheng Li,Xiaofeng Chen

Cancer science (2024)

引用0浏览0WOS引用

Soluble PD-L1 As a Novel Biomarker Predicts Poor Outcomes and Disease Progression in De Novo Myelodysplastic Syndromes

Xingcheng Yang,Lijun Jiang,Xiaoying Zhang, Juan Peng,Hu Qian,Lifang Huang,Shaolong He,Zhiqiong Wang,Liting Chen,Yicheng Zhang,Ling Ma,Yuan Chen,Jia Wei

Biomarker Researchno. 1 (2024): 1-5

引用0浏览0WOS引用

New Advances in Cancer Therapy Targeting TGF-β Signaling Pathways

Minyue Shou,Hanyu Zhou,Ling Ma

Molecular Therapy - Oncolytics (2023)

引用0浏览0引用

Immuno-genomic-radiomics to Predict Response of Biliary Tract Cancer to Camrelizumab Plus GEMOX in a Single-Arm Phase II Trial

Qiu-Ping Liu,Jie Tang,Yi-Zhang Chen,Fen Guo,Ling Ma,Lan-Lan Pan,Yi-Tong Tian,Xiao-Feng Wu,Yu-Dong Zhang,Xiao-Feng Chen

JHEP REPORTSno. 7 (2023)

引用0浏览0WOS引用

New advances in cancer therapy targeting TGF-13 signaling pathways

Minyue Shou,Hanyu Zhou,Ling Ma

MOLECULAR THERAPY ONCOLYTICS (2023)

引用0浏览0引用

Epigenetic Reactivation of PEG3 by EZH2 Inhibitors Suppresses Renal Clear Cell Carcinoma Progress

Teng Qiu,Yuanyuan Ding,Jingting Qin,Dexu Ren,Mengru Xie,Qilan Qian,Yasong Wang,Ling Ma,Aixin Jing,Jiayan Yang,Shaojie Ma,Xiujun Wang,Weiling Wang,Jing Ji,Guanchu Li

Cellular Signalling (2023): 110662-110662

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn